IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v19y2022i11p6463-d824573.html
   My bibliography  Save this article

Adverse Events in Isotretinoin Therapy: A Single-Arm Meta-Analysis

Author

Listed:
  • Jan Kapała

    (Medical Faculty, University of Warmia and Mazury in Olsztyn, 10-719 Olsztyn, Poland)

  • Julia Lewandowska

    (Medical Faculty, University of Warmia and Mazury in Olsztyn, 10-719 Olsztyn, Poland)

  • Waldemar Placek

    (Department of Dermatology Sexually Transmitted Diseases and Clinical Immunology, University of Warmia and Mazury in Olsztyn, 10-719 Olsztyn, Poland)

  • Agnieszka Owczarczyk-Saczonek

    (Department of Dermatology Sexually Transmitted Diseases and Clinical Immunology, University of Warmia and Mazury in Olsztyn, 10-719 Olsztyn, Poland)

Abstract

Isotretinoin (ISO) is an oral prescription-only retinoid, well known for its acne-treating effect. However, it affects a substantial number of human cell types, causing a broad spectrum of adverse effects. The purpose of this study is to establish the isotretinoin therapy adverse events among human clinical trials and their prevalence. Two authors (J.K., J.L.) systematically performed the literature review and assessment from December 2021–February 2022. Three databases (PubMed, ClinicalTrials, and Cochrane Library) were searched using the following terms: “isotretinoin acne vulgaris” for published studies in English from 1980–2021. Finally, 25 randomized controlled clinical trials (RCTs) and five open-label clinical trials provided 3274 acne vulgaris suffering patients. Isotretinoin therapy affects almost all of the systems in the human body, causing numerous adverse events. However, they mainly concern mild mucocutaneous conditions (severe cases are rare) and represent individual responses to a drug. In addition, all adverse events are reversible and can be avoided by specific preparations.

Suggested Citation

  • Jan Kapała & Julia Lewandowska & Waldemar Placek & Agnieszka Owczarczyk-Saczonek, 2022. "Adverse Events in Isotretinoin Therapy: A Single-Arm Meta-Analysis," IJERPH, MDPI, vol. 19(11), pages 1-21, May.
    • Handle: RePEc:gam:jijerp:v:19:y:2022:i:11:p:6463-:d:824573
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/19/11/6463/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/19/11/6463/
    Download Restriction: no
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:11:p:6463-:d:824573. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.